191 reports of this reaction
2.1% of all CYPROHEPTADINE HYDROCHLORIDE reports
#8 most reported adverse reaction
HEADACHE is the #8 most commonly reported adverse reaction for CYPROHEPTADINE HYDROCHLORIDE, manufactured by Chartwell RX, LLC. There are 191 FDA adverse event reports linking CYPROHEPTADINE HYDROCHLORIDE to HEADACHE. This represents approximately 2.1% of all 9,068 adverse event reports for this drug.
Patients taking CYPROHEPTADINE HYDROCHLORIDE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for CYPROHEPTADINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for CYPROHEPTADINE HYDROCHLORIDE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 191 FDA reports for CYPROHEPTADINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.1% of all adverse event reports for CYPROHEPTADINE HYDROCHLORIDE, making it a notable side effect.
If you experience headache while taking CYPROHEPTADINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.